3,4-Dimethoxybenzamide

CAS No. 1521-41-1

3,4-Dimethoxybenzamide ( —— )

Catalog No. M28208 CAS No. 1521-41-1

3,4-Dimethoxybenzamide, amide, is isolated from the solid culture of Streptoverticillium morookaense. 3,4-Dimethoxybenzamide can be used as the starting material to preparation Itopride hydrochloride.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 45 In Stock
100MG 68 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3,4-Dimethoxybenzamide
  • Note
    Research use only, not for human use.
  • Brief Description
    3,4-Dimethoxybenzamide, amide, is isolated from the solid culture of Streptoverticillium morookaense. 3,4-Dimethoxybenzamide can be used as the starting material to preparation Itopride hydrochloride.
  • Description
    3,4-Dimethoxybenzamide, amide, is isolated from the solid culture of Streptoverticillium morookaense . 3,4-Dimethoxybenzamide can be used as the starting material to preparation Itopride hydrochloride.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    urotensin-II (UT)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1521-41-1
  • Formula Weight
    181.2
  • Molecular Formula
    C9H11NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1ccc(cc1OC)C(N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cosenzi A. Non peptidic urotensin II antagonists: perspectives for a new class of drugs. Cardiovasc Hematol Agents Med Chem. 2008 Apr;6(2):80-91.
molnova catalog
related products
  • VPC-18005

    VPC-18005 is a luciferase inhibitor. VPC-18005 inhibits ERG-induced transcription and interacts directly with the ERG-ETS domain thereby disrupting the ERG binding to DNA.

  • Soyasaponin Ba

    Soyasaponin Ba may represent viable candidates for effective vaccine adjuvants due to their higher and lower or non-haemolytic effects.

  • Apraglutide TFA (129...

    Apraglutide TFA (FE 203799 TFA), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum.